Cargando…
Novel Evidence of Acute Kidney Injury in COVID-19
The coronavirus 2019 (COVID-19) pandemic has caused a huge impact on health and economic issues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes cellular damage by entry mediated by the angiotensin-converting enzyme 2 of the host cells and its conjugation with spike proteins of S...
Autores principales: | Chueh, Ti-I, Zheng, Cai-Mei, Hou, Yi-Chou, Lu, Kuo-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692179/ https://www.ncbi.nlm.nih.gov/pubmed/33153216 http://dx.doi.org/10.3390/jcm9113547 |
Ejemplares similares
-
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review
por: Hou, Yi-Chou, et al.
Publicado: (2021) -
Editorial comment on Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence – The role of Vitamin K in managing chronic kidney disease–mineral bone disorder
por: Hou, Yi-Chou, et al.
Publicado: (2022) -
Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
por: Liao, Yu-Huang, et al.
Publicado: (2020) -
Metabolic Acidosis and Strong Ion Gap in Critically Ill Patients with Acute Kidney Injury
por: Zheng, Cai-Mei, et al.
Publicado: (2014) -
Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
por: Hou, Yi-Chou, et al.
Publicado: (2022)